Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Mitophagy in the pathogenesis and management of disease

Open access
Wang, Qi, Sun, Yu, Li, Terytty Yang, Auwerx, Johan · 2026 · Cell Research

Abstract

Mitophagy, an evolutionarily conserved quality-control process, selectively removes damaged mitochondria to maintain cellular homeostasis. Recent advances in our understanding of the molecular machinery underlying mitophagy — from receptors and stress-responsive triggers to lysosomal degradation — illustrate its key role in maintaining mitochondrial integrity and adapting mitochondrial function to ever-changing physiological demands. In this review, we outline the fundamental mechanisms of mitophagy and discuss how dysregulation of this pathway disrupts mitochondrial function and metabolic balance, driving a wide range of disorders, including neurodegenerative, cardiovascular, metabolic, and immune-related diseases, as well as cancer. We explore the dual role of mitophagy as both a disease driver and a therapeutic target, highlighting the efforts and challenges of translating mechanistic insights into precision therapies. Targeting mitophagy to restore mitochondrial homeostasis may be at the center of a large range of translational opportunities for improving human health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41422-025-01203-7

Cites

Statistics

Figures

Image 1
CC-BY · From the PDF
Fig. 1 PINK1 -Parkin-mediated mitophagy. a The rapid turnover of PINK1 under normal conditions. The N-terminus of PINK1 is imported into healthy mitochondria and processed by MPP and PARL, generating a cleaved PINK1 that is recognized by ubiquitin ligases and targeted for proteasomal degradation. b PINK1 accumulation on damaged mitochondria leads to Parkin recruitment and ubiquitin chain buildup. Mitochondrial damage causes mitochondrial depolarization, which inhibits PINK1 import, allowing PINK1 to complex with TOM on the OMM. Accumulated PINK1 undergoes dimerization and transactivation, phosphorylating Ser65 of the ubiquitin on OMM proteins to generate pUb. Parkin binds to these pUbs and becomes activated, decorating damaged mitochondria with ubiquitin chains. c Ubiquitinated mitochondria recruit selective autophagy receptors to drive mitophagy. Selective autophagy receptors such as NDP52 and OPTN bind to ubiquitin chains on the mitochondria and interact with upstream autophagy modules to initiate autophagosome formation. OMM outer mitochondrial membrane, IMS intermembrane space, IMM inner mitochondrial membrane, TOM translocase of the outer membrane, TIM translocase of the inner membrane, Δψ membrane potential.
Fig. 1 PINK1 -Parkin-mediated mitophagy. a The rapid turnover of PINK1 under normal conditions. The N-terminus of PINK1 is imported into healthy mitochondria and processed by MPP and PARL, generating a cleaved PINK1 that is recognized by ubiquitin ligases and targeted for proteasomal degradation. b PINK1 accumulation on damaged mitochondria leads to Parkin recruitment and ubiquitin chain buildup. Mitochondrial damage causes mitochondrial depolarization, which inhibits PINK1 import, allowing PINK1 to complex with TOM on the OMM. Accumulated PINK1 undergoes dimerization and transactivation, phosphorylating Ser65 of the ubiquitin on OMM proteins to generate pUb. Parkin binds to these pUbs and becomes activated, decorating damaged mitochondria with ubiquitin chains. c Ubiquitinated mitochondria recruit selective autophagy receptors to drive mitophagy. Selective autophagy receptors such as NDP52 and OPTN bind to ubiquitin chains on the mitochondria and interact with upstream autophagy modules to initiate autophagosome formation. OMM outer mitochondrial membrane, IMS intermembrane space, IMM inner mitochondrial membrane, TOM translocase of the outer membrane, TIM translocase of the inner membrane, Δψ membrane potential.CC-BY · From the PDF
Fig. 2 Receptor-mediated mitophagy pathways. PINK1 -Parkin-independent regulatory mechanisms are shown. a , b BNIP3/NIX-mediated mitophagy. a Functional domains of BNIP3 and NIX are shown on top. Under normal conditions, the mitochondrial E3 ligase complex SCF FBXL4 , which is composed of CUL1 -SKP1 -FBXL4, interacts with RBX1 and the E2 enzyme to ubiquitinate BNIP3 and NIX for proteasomal degradation. OM-PPTC7 facilitates the interaction between SCF FBXL4 and BNIP3/NIX. b Under hypoxia, HIF-1 α upregulates the transcription of BNIP3/NIX. JNK1/2 phosphorylate BNIP3 to inhibit its degradation. Accumulated BNIP3/NIX proteins form homodimers and recruit LC3 via their LIR. ULK1 phosphorylates BNIP3/NIX to promote mitophagy. c FUNDC1-mediated mitophagy. Functional domains of FUNDC1 are shown on top. Under normal conditions, CK2 and Src phosphorylate FUNDC1 to prevent its interaction with LC3. The E3 ligase MARCH5 ubiquitinates FUNDC1 for proteasomal degradation, and this is antagonized by USP19. Upon hypoxia or a decrease in membrane potential, PGAM5 dephosphorylates FUNDC1 to promote its binding with LC3. ULK1 phosphorylates FUNDC1 to facilitate its LC3 recruitment. d BCL2L13, FKBP8, AMBRA1, and PHB2 as mitophagy receptors. Functional domains of BCL2L13, FKBP8, AMBRA1, and PHB2 are shown. These receptors mediate mitophagy by recruiting LC3 via their LIR domains. In addition, BCL2L13 complexes with ULK1 and LC3 during the initiation of mitophagy. AMBRA1 recruits the E3 ligase HUWE1 to ubiquitinate MFN2 and other OMM proteins to facilitate mitophagy, and its phosphorylation by IKK α also promotes mitophagy. PHB2, an IMM-located mitophagy receptor, acquires access to LC3 upon outer membrane rupture. OMM outer mitochondrial membrane, IMS intermembrane space, IMM inner mitochondrial membrane; LIR LC3-interacting region, BH1 -4 Bcl-2 homology domain 1 -4, TM transmembrane domain, WD40 WD40 domain, PHB prohibitin domain.
Fig. 2 Receptor-mediated mitophagy pathways. PINK1 -Parkin-independent regulatory mechanisms are shown. a , b BNIP3/NIX-mediated mitophagy. a Functional domains of BNIP3 and NIX are shown on top. Under normal conditions, the mitochondrial E3 ligase complex SCF FBXL4 , which is composed of CUL1 -SKP1 -FBXL4, interacts with RBX1 and the E2 enzyme to ubiquitinate BNIP3 and NIX for proteasomal degradation. OM-PPTC7 facilitates the interaction between SCF FBXL4 and BNIP3/NIX. b Under hypoxia, HIF-1 α upregulates the transcription of BNIP3/NIX. JNK1/2 phosphorylate BNIP3 to inhibit its degradation. Accumulated BNIP3/NIX proteins form homodimers and recruit LC3 via their LIR. ULK1 phosphorylates BNIP3/NIX to promote mitophagy. c FUNDC1-mediated mitophagy. Functional domains of FUNDC1 are shown on top. Under normal conditions, CK2 and Src phosphorylate FUNDC1 to prevent its interaction with LC3. The E3 ligase MARCH5 ubiquitinates FUNDC1 for proteasomal degradation, and this is antagonized by USP19. Upon hypoxia or a decrease in membrane potential, PGAM5 dephosphorylates FUNDC1 to promote its binding with LC3. ULK1 phosphorylates FUNDC1 to facilitate its LC3 recruitment. d BCL2L13, FKBP8, AMBRA1, and PHB2 as mitophagy receptors. Functional domains of BCL2L13, FKBP8, AMBRA1, and PHB2 are shown. These receptors mediate mitophagy by recruiting LC3 via their LIR domains. In addition, BCL2L13 complexes with ULK1 and LC3 during the initiation of mitophagy. AMBRA1 recruits the E3 ligase HUWE1 to ubiquitinate MFN2 and other OMM proteins to facilitate mitophagy, and its phosphorylation by IKK α also promotes mitophagy. PHB2, an IMM-located mitophagy receptor, acquires access to LC3 upon outer membrane rupture. OMM outer mitochondrial membrane, IMS intermembrane space, IMM inner mitochondrial membrane; LIR LC3-interacting region, BH1 -4 Bcl-2 homology domain 1 -4, TM transmembrane domain, WD40 WD40 domain, PHB prohibitin domain.CC-BY · From the PDF
Fig. 3 Summary of mitophagy-associated human diseases. This review discusses the mitophagy dysregulation underlying neurodegenerative, cardiovascular, metabolic, and immune-related disorders, as well as cancer.
Fig. 3 Summary of mitophagy-associated human diseases. This review discusses the mitophagy dysregulation underlying neurodegenerative, cardiovascular, metabolic, and immune-related disorders, as well as cancer.CC-BY · From the PDF
Fig. 4 Selective mitophagy inducers targeting the PINK1 -Parkin pathway. a Schematic overview of mitophagy activators and their targets. b Structure of PINK1 activators. c Structure of a PARL inhibitor. d Structure of a Parkin activator. e Structure of USP30 inhibitors.
Fig. 4 Selective mitophagy inducers targeting the PINK1 -Parkin pathway. a Schematic overview of mitophagy activators and their targets. b Structure of PINK1 activators. c Structure of a PARL inhibitor. d Structure of a Parkin activator. e Structure of USP30 inhibitors.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 498 · Cited by 103

Research works printed but not linked: 8

  1. Sowter, H. M., Ratcliffe, P. J., Watson, P., Greenberg, A. H. & Harris, A. L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61, 6669–6673 (2001).
  2. Wang, J. et al. BCL2L13 promotes mitophagy through DNM1L-mediated mitochondrial fission in glioblastoma. Cell Death Dis. 14, 1–13 (2023).
  3. He, H., Tang, Y., Zhuang, L., Zheng, Y. & Huang, X. PINK1/Park2-mediated mitophagy relieve non-alcoholic fatty liver disease. Physiol. Res. 73, 253–263 (2024).
  4. Liu, S. et al. Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: A randomized clinical trial. JAMA Netw. Open 5, e2144279 (2022).
  5. Dunmore, R. et al. Abstract 4135531: The ubiquitin-specific protease 30 inhibitor, MTX652, attenuates cardiac dysfunction and remodelling in a murine model of transverse aortic constriction. Am. Heart Association’s 2024 Sci. Sessions 150, A4135531–A4135531 (2024).
  6. Aceves, P., Thompson, P. W., Jones, N. & Nurbhai, S. Abstract TH-OR93: MTX652, a novel selective USP30 inhibitor for the treatment of AKI: Phase 1 results in healthy subjects and model-driven human efficacious dose pojections. Am. Soc. Nephrol. Kidney Week 2023 34, 27 (2023).
  7. Gaffney, K., Erion, K. & Rodgers, K. Poster S31: CAP-1902 enhances muscle function in mdx mice. MDA Clinical and Scientific Conference 2025 https://www.mdaconference.org/abstract-library/cap-1902-enhances-muscle-function-in-mdx-mice/.
  8. McLelland, G., Soubannier, V., Chen, C. X., McBride, H. M. & Fon, E. A. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 33, 282–295 (2014).

Metadata

Authors
Wang, Q., Sun, Y., Li, T. Y., & Auwerx, J.
Affiliations
  • École Polytechnique Fédérale de Lausanne (CH)
  • Fudan University (CN)
Corresponding author
  • Li, Terytty Yang
  • Auwerx, Johan
Venue
Cell Research
Published
2026-01-05
Volume
36
Issue
1
Pages
11-37
ISSN
  • 1001-0602 (ISSN-L)
  • 1748-7838
OpenAlex
W7118163876
Cited by
103
References
498
Citations by year
2026: 103
FWCI
118.79
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNSF 31003A_179435, Sinergia CRSII5_202302)
  • European Molecular Biology Organization (ALTF 111-2021)
  • BrightFocus Foundation (A2023018F)
  • China Postdoctoral Science Foundation (2023TQ0080)
  • National Natural Science Foundation of China (82300708, 2021hwyq47, 32470816)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
mitophagy, mitochondrial quality control, mitochondrial homeostasis, mitophagy receptors, lysosomal degradation, mitochondrial dysfunction, neurodegenerative diseases, cardiovascular disease, metabolic disorders, immune-related diseases, cancer, therapeutic target, precision medicine
MeSH terms
Animals, Humans, Mitochondria, Neoplasms, Neurodegenerative Diseases, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitophagy in the pathogenesis and management of disease. https://app.cochat.ai/papers/10.1038/s41422-025-01203-7
The paper
Wang, Q., Sun, Y., Li, T. Y., & Auwerx, J. (2026). Mitophagy in the pathogenesis and management of disease. Cell Research. https://doi.org/10.1038/s41422-025-01203-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.